These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18729286)

  • 1. [Don't stop me now!].
    Wolf A; Schaack J; Freikamp L; Reutzel S; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):356-7. PubMed ID: 18729286
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy.
    Duan D
    Curr Opin Mol Ther; 2008 Feb; 10(1):86-94. PubMed ID: 18228186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy: the 'pro-sense' approach to Duchenne muscular dystrophy.
    van Deutekom JC
    Eur J Hum Genet; 2005 May; 13(5):518-9. PubMed ID: 15714219
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in Duchenne muscular dystrophy gene therapy.
    van Deutekom JC; van Ommen GJ
    Nat Rev Genet; 2003 Oct; 4(10):774-83. PubMed ID: 14526374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics. Hopping to a better protein.
    Pennisi E
    Science; 2008 Dec; 322(5907):1454-5. PubMed ID: 19056949
    [No Abstract]   [Full Text] [Related]  

  • 7. [Duchenne muscular dystrophy].
    Ishihara T
    Ryoikibetsu Shokogun Shirizu; 2001; (35):14-7. PubMed ID: 11555892
    [No Abstract]   [Full Text] [Related]  

  • 8. Technology insight: therapy for Duchenne muscular dystrophy-an opportunity for personalized medicine?
    Lim LE; Rando TA
    Nat Clin Pract Neurol; 2008 Mar; 4(3):149-58. PubMed ID: 18268530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
    Jørgensen LH; Larochelle N; Orlopp K; Dunant P; Dudley RW; Stucka R; Thirion C; Walter MC; Laval SH; Lochmüller H
    Hum Gene Ther; 2009 Jun; 20(6):641-50. PubMed ID: 19239382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When running a stop sign may be a good thing.
    Karpati G; Lochmuller H
    Ann Neurol; 2001 Jun; 49(6):693-4. PubMed ID: 11409418
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy.
    Lai Y; Li D; Yue Y; Duan D
    Methods Mol Biol; 2008; 433():259-75. PubMed ID: 18679629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne muscular dystrophy improved by gentamicin.
    Senior K
    Mol Med Today; 1999 Nov; 5(11):461. PubMed ID: 10529784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Becker muscular dystrophy].
    Ishihara T
    Ryoikibetsu Shokogun Shirizu; 2001; (35):18-22. PubMed ID: 11555904
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
    Wang B; Li J; Fu FH; Xiao X
    J Orthop Res; 2009 Apr; 27(4):421-6. PubMed ID: 18973234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for duchenne muscular dystrophy: expectations and challenges.
    Rodino-Klapac LR; Chicoine LG; Kaspar BK; Mendell JR
    Arch Neurol; 2007 Sep; 64(9):1236-41. PubMed ID: 17846262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to gene therapy: a clinical aftermath.
    Denèfle PP
    Methods Mol Biol; 2011; 737():27-44. PubMed ID: 21590392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.
    Wu B; Moulton HM; Iversen PL; Jiang J; Li J; Li J; Spurney CF; Sali A; Guerron AD; Nagaraju K; Doran T; Lu P; Xiao X; Lu QL
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14814-9. PubMed ID: 18806224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of Duchenne muscular dystrophy.
    Manzur AY; Kinali M; Muntoni F
    Arch Dis Child; 2008 Nov; 93(11):986-90. PubMed ID: 18667451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
    Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
    Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction of recombinant plasmid pVAX1-microdystrophin and preliminary study on the treatment to Duchenne muscular dystrophy].
    Xiong F; Zhang C; Zheng H; Xiao S; Yu M; Xu Y; Liu Z; Zhou C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):624-8. PubMed ID: 19065517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.